研究论文开放获取
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava, Marlene P. Freeman, Martina Flynn, Heidi Judge, Bettina B. Hoeppner, Cristina Cusin, Dawn F. Ionescu, Sanjay J. Mathew 等 18 位
Massachusetts General Hospital Michael E. DeBakey VA Medical Center Baylor College of Medicine Icahn School of Medicine at Mount Sinai
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
83420
18
19
20
21
22
23
8324
25
26
关键指标
440
被引次数 · OpenAlex
24.86
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 0.2%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
37
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Treatment of Major Depression
Tryptophan and brain disorders · Mental Health Research Topics
参考文献 37
Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program.
被引 275Jan Fawcett, P Epstein, Susan J. Fiester · PubMed · 1987
Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder
被引 179Michael E. Thase, James M. Youakim, Aleksandar Skuban · The Journal of Clinical Psychiatry · 2015
The Hamilton Depression Scale
被引 427Per Bech, Peter Allerup, L. F. Gram · Acta Psychiatrica Scandinavica · 1981
此处列出前 3 条
引用本文 440
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
被引 778Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune · World Psychiatry · 2023
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
被引 715Roger S. McIntyre, Joshua D. Rosenblat, Charles B. Nemeroff · American Journal of Psychiatry · 2021
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
被引 428Amir Garakani, James W. Murrough, Rafael C. Freire · Frontiers in Psychiatry · 2020
按被引量排序，此处列出前 3 条